OPS
AMAG

Orion Portfolio Solutions’s AMAG Pharmaceuticals AMAG Stock Holding History

Orion Portfolio Solutions’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-96
Closed -$1K – 2352
2020
Q2 		$1K Buy
+96
New +$735 ﹤0.01% 2142

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Orion Portfolio Solutions's AMAG Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 96 shares — an estimated $1K sold.

Orion Portfolio Solutions first reported a position in AMAG in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 96 AMAG Pharmaceuticals shares in Q3 2020, an estimated $1K.
  • Orion Portfolio Solutions first reported a position in AMAG Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Orion Portfolio Solutions's AMAG Pharmaceuticals position peaked at $1K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.